Quarterly report pursuant to Section 13 or 15(d)

SEGMENT INFORMATION (Tables)

v3.20.2
SEGMENT INFORMATION (Tables)
6 Months Ended
Jun. 30, 2020
DESCRIPTION OF BUSINESS  
Schedule of summarized financial information

 

 

As of and For the Three Months Ended June 30, 2020

(Unaudited)

(in thousands)

 

 

 

Cannabis

 

 

Corporate / CBD

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$ 3,007

 

 

$ 301

 

 

$ 3,308

 

Cost of Goods Sold

 

 

1,759

 

 

 

157

 

 

 

1,916

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

1,248

 

 

 

144

 

 

 

1,392

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

3,606

 

 

 

3,770

 

 

 

7,377

 

Impairment of Assets

 

 

4,998

 

 

 

6,316

 

 

 

11,314

 

(Gain) / Loss on Sale of Assets

 

 

-

 

 

 

-

 

 

 

-

 

(Gain) / Loss on Interest in Joint Venture

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(7,356 )

 

 

(9,943 )

 

 

(17,299 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income (Expense)

 

 

(243 )

 

 

(599 )

 

 

(842 )

Other Income / (Loss)

 

 

(89 )

 

 

1

 

 

 

(88 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income (Expense)

 

 

(332 )

 

 

(598 )

 

 

(930 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) from continuing operations

 

$ (7,688 )

 

$ (10,541 )

 

$ (18,229 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at June 30, 2020

 

$ 69,684

 

 

$ 20,862

 

 

$ 90,546

 

      

 

 

As of and For the Six Months Ended June 30, 2020

(Unaudited)

(in thousands)

 

 

 

Cannabis

 

 

Corporate / CBD

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$ 6,753

 

 

$ 868

 

 

$ 7,621

 

Cost of Goods Sold

 

 

3,181

 

 

 

710

 

 

 

3,891

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

3,572

 

 

 

158

 

 

 

3,730

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

7,484

 

 

 

8,929

 

 

 

16,414

 

Impairment of Assets

 

 

10,118

 

 

 

6,316

 

 

 

16,434

 

(Gain) / Loss on Sale of Assets

 

 

(35 )

 

 

-

 

 

 

(35 )

(Gain) / Loss on Interest in Joint Venture

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(13,995 )

 

 

(15,087 )

 

 

(29,082 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income (Expense)

 

 

(488 )

 

 

(1,256 )

 

 

(1,744 )

Other Income / (Loss)

 

 

(51 )

 

 

28

 

 

 

(23 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income (Expense)

 

 

(539 )

 

 

(1,228 )

 

 

(1,767 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) from continuing operations

 

$ (14,534 )

 

$ (16,315 )

 

$ (30,849 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at June 30, 2020

 

$ 69,684

 

 

$ 20,862

 

 

$ 90,546

 

 

 

As of and For the Three Months Ended June 30, 2019

(Unaudited)

(in thousands)

 

 

 

Cannabis

 

 

Corporate / CBD

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$ 4,477

 

 

$ -

 

 

$ 4,477

 

Cost of Goods Sold

 

 

2,177

 

 

 

-

 

 

 

2,177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

2,300

 

 

 

-

 

 

 

2,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

3,402

 

 

 

5,211

 

 

 

8,613

 

Impairment of Assets

 

 

114

 

 

 

396

 

 

 

510

 

(Gain) / Loss on Sale of Assets

 

 

-

 

 

 

-

 

 

 

-

 

(Gain) / Loss on Interest in Joint Venture

 

 

(0 )

 

 

-

 

 

 

(0 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(1,215 )

 

 

(5,607 )

 

 

(6,822 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income (Expense)

 

 

(305 )

 

 

(3,314 )

 

 

(3,620 )

Other Income / (Loss)

 

 

(12 )

 

 

997

 

 

 

985

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income (Expense)

 

 

(318 )

 

 

(2,318 )

 

 

(2,635 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) from continuing operations

 

$ (1,533 )

 

$ (7,924 )

 

$ (9,457 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at June 30, 2019

 

$ 92,974

 

 

$ 9,941

 

 

$ 102,916

 

  

 

 

As of and For the Six Months Ended June 30, 2019

(Unaudited)

(in thousands)

 

 

 

Cannabis

 

 

Corporate / CBD

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$ 6,522

 

 

$ -

 

 

$ 6,522

 

Cost of Goods Sold

 

 

2,622

 

 

 

-

 

 

 

2,622

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

3,900

 

 

 

-

 

 

 

3,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

6,454

 

 

 

10,750

 

 

 

17,204

 

Impairment of Assets

 

 

114

 

 

 

396

 

 

 

510

 

(Gain) / Loss on Sale of Assets

 

 

-

 

 

 

-

 

 

 

-

 

(Gain) / Loss on Interest in Joint Venture

 

 

1,067

 

 

 

-

 

 

 

1,067

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(3,734 )

 

 

(11,146 )

 

 

(14,880 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income (Expense)

 

 

(532 )

 

 

(6,015 )

 

 

(6,548 )

Other Income / (Loss)

 

 

(12 )

 

 

1,009

 

 

 

997

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income (Expense)

 

 

(545 )

 

 

(5,007 )

 

 

(5,551 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) from continuing operations

 

$ (4,279 )

 

$ (16,152 )

 

$ (20,431 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at June 30, 2019

 

$ 92,974

 

 

$ 9,941

 

 

$ 102,916